Pacific Biosciences of Californ - stock earnings
PACB Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q4 | -82.0 million USD | 58.4 million USD |
| 2023Q3 | -66.9 million USD | 55.7 million USD |
| 2023Q2 | -69.8 million USD | 47.6 million USD |
| 2023Q1 | -81.1 million USD | 38.9 million USD |
| 2022Q4 | -79.8 million USD | 27.4 million USD |
| 2022Q3 | -83.6 million USD | 32.3 million USD |
| 2022Q2 | -69.4 million USD | 35.5 million USD |
| 2022Q1 | -84.4 million USD | 33.2 million USD |
| 2021Q4 | -69.3 million USD | 36.0 million USD |
| 2021Q3 | 16.5 million USD | 34.9 million USD |
| 2021Q2 | -41.0 million USD | 30.6 million USD |
| 2021Q1 | -87.4 million USD | 29.0 million USD |
| 2020Q4 | 74.9 million USD | 27.1 million USD |
| 2020Q3 | -23.7 million USD | 19.1 million USD |
| 2020Q2 | -23.1 million USD | 17.1 million USD |
| 2020Q1 | 1.3 million USD | 15.6 million USD |
| 2019Q4 | -91000 USD | 27.9 million USD |
| 2019Q3 | -29.1 million USD | 21.9 million USD |
| 2019Q2 | -24.6 million USD | 24.6 million USD |
| 2019Q1 | -30.3 million USD | 16.4 million USD |
| 2018Q4 | -30.8 million USD | 19.5 million USD |
| 2018Q3 | -25.0 million USD | 18.2 million USD |
| 2018Q2 | -22.5 million USD | 21.6 million USD |
| 2018Q1 | -24.2 million USD | 19.4 million USD |
| 2017Q4 | -20.8 million USD | 24.9 million USD |
| 2017Q3 | -22.0 million USD | 23.5 million USD |
| 2017Q2 | -25.5 million USD | 20.1 million USD |
| 2017Q1 | -23.9 million USD | 24.9 million USD |
| 2016Q4 | -19.0 million USD | 25.7 million USD |
| 2016Q3 | -17.5 million USD | 25.1 million USD |
| 2016Q2 | -18.5 million USD | 20.7 million USD |
| 2016Q1 | -19.4 million USD | 19.1 million USD |
| 2015Q4 | -1.4 million USD | 36.3 million USD |
| 2015Q3 | 1.8 million USD | 13.9 million USD |
| 2015Q2 | -11.9 million USD | 24.9 million USD |
| 2015Q1 | -20.2 million USD | 17.6 million USD |
| 2014Q4 | -19.0 million USD | 16.9 million USD |
| 2014Q3 | -9.2 million USD | 20.6 million USD |
| 2014Q2 | -19.1 million USD | 11.4 million USD |
| 2014Q1 | -18.9 million USD | 11.6 million USD |
| 2013Q4 | -17.2 million USD | 9.1 million USD |
| 2013Q3 | -20.5 million USD | 7.4 million USD |
| 2013Q2 | -20.5 million USD | 6.0 million USD |
| 2013Q1 | -21.1 million USD | 5.6 million USD |
| 2012Q4 | -21.7 million USD | 5.9 million USD |
| 2012Q3 | -22.7 million USD | 2.8 million USD |
| 2012Q2 | -22.5 million USD | 7.3 million USD |
| 2012Q1 | -27.6 million USD | 10.0 million USD |
| 2011Q4 | -22.8 million USD | 12.4 million USD |
| 2011Q3 | -29.3 million USD | 10.5 million USD |
| 2011Q2 | -22.5 million USD | 10.6 million USD |
| 2011Q1 | -34.8 million USD | 270000 USD |
| 2010Q4 | -36.4 million USD | 280000 USD |
| 2010Q3 | -40.7 million USD | 220000 USD |
| 2010Q2 | -32.7 million USD | 629000 USD |
| 2010Q1 | -30.3 million USD | 545000 USD |
| 2009Q4 | -28.1 million USD | 135000 USD |
| 2009Q3 | -24.5 million USD | ? USD |
| 2008Q4 | ? USD | 901000 USD |
PACB Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -306.7 million USD | 200.5 million USD |
| 2022 | -296.9 million USD | 128.3 million USD |
| 2021 | -181.2 million USD | 130.5 million USD |
| 2020 | 29.4 million USD | 78.9 million USD |
| 2019 | -77.8 million USD | 90.9 million USD |
| 2018 | -102.6 million USD | 78.6 million USD |
| 2017 | -92.2 million USD | 93.5 million USD |
| 2016 | -74.4 million USD | 90.7 million USD |
| 2015 | -31.7 million USD | 92.8 million USD |
| 2014 | -66.2 million USD | 60.6 million USD |
| 2013 | -79.3 million USD | 28.2 million USD |
| 2012 | -94.5 million USD | 26.0 million USD |
| 2011 | -109.4 million USD | 33.9 million USD |
| 2010 | -140.2 million USD | 1.7 million USD |
| 2009 | -87.7 million USD | 135000 USD |
| 2008 | -43.8 million USD | 901000 USD |
| 2007 | -21.5 million USD | 2.2 million USD |
PACB
Price: $1.47
52 week price:
Payout Ratio Range:
Earnings Per Share: -1.21 USD
P/E Ratio: -5.11
Exchange: NMS
Sector: Healthcare
Industry: Medical Devices
Volume: 5.8 million
Ebitda: -20.1 millionMarket Capitalization: 892.3 million